Pricing Log in Create free account

Vor Biopharma Inc. (VOR) vs Verastem, Inc. (VSTM)

Vor Biopharma Inc. and Verastem, Inc. are both Biotechnology companies. Vor Biopharma Inc. and Verastem, Inc. are of similar size ($1.2B and $1.1B). Vor Biopharma Inc. has the higher net margin (0.00% vs −178.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Vor Biopharma Inc. leads on 6 and Verastem, Inc. on 5.

Valuation

Metric VOR VSTM Biotechnology median
P/E n/m n/m 10.60
P/S n/m 8.51 9.40
P/B 0.38 84.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.50 n/m 0.66
EV/Sales n/m 7.98 9.02
Earnings yield (1,910.79%) (21.95%) (32.88%)
Free cash flow yield (141.07%) (18.70%) (23.13%)

Profitability

Metric VOR VSTM Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin — (193.73%) 0.00%
Net margin 0.00% (178.38%) 0.00%
Free cash flow margin 0.00% (159.10%) 0.00%
Return on equity (69.27%) 6,595.50% (51.96%)
Return on assets 0.00% (88.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric VOR VSTM Biotechnology median
Revenue growth (TTM) — 286.13% 6.76%
EPS growth (last fiscal year) (107.35%) 17.49% 29.88%
Revenue growth, 5-year CAGR — 12.11% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VOR VSTM Biotechnology median
Debt to equity 0.21 11.82 0.00
Current ratio 10.69 1.93 4.97
Net debt to EBITDA 2.27 0.76 1.01

Dividend

Metric VOR VSTM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VOR VSTM Biotechnology median
Market cap 1.15b 1.14b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack